TARKA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tarka, and what generic alternatives are available?
Tarka is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in TARKA is trandolapril; verapamil hydrochloride. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trandolapril; verapamil hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tarka
A generic version of TARKA was approved as trandolapril; verapamil hydrochloride by GLENMARK PHARMS LTD on May 5th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TARKA?
- What are the global sales for TARKA?
- What is Average Wholesale Price for TARKA?
Summary for TARKA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Patent Applications: | 4,179 |
Drug Prices: | Drug price information for TARKA |
What excipients (inactive ingredients) are in TARKA? | TARKA excipients list |
DailyMed Link: | TARKA at DailyMed |
Paragraph IV (Patent) Challenges for TARKA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TARKA | Extended-release Tablets | trandolapril; verapamil hydrochloride | 1 mg/240 mg | 020591 | 1 | 2008-02-20 |
TARKA | Extended-release Tablets | trandolapril; verapamil hydrochloride | 2 mg/180 mg and 2 mg/240 mg | 020591 | 1 | 2007-11-09 |
TARKA | Extended-release Tablets | trandolapril; verapamil hydrochloride | 4 mg/ 240 mg | 020591 | 1 | 2007-07-24 |
US Patents and Regulatory Information for TARKA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | TARKA | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020591-003 | Oct 22, 1996 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Abbvie | TARKA | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020591-002 | Oct 22, 1996 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Abbvie | TARKA | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020591-001 | Oct 22, 1996 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Abbvie | TARKA | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020591-004 | Oct 22, 1996 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TARKA
International Patents for TARKA
See the table below for patents covering TARKA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 119992 | ⤷ Subscribe | |
Japan | 2752043 | ⤷ Subscribe | |
Norway | 832741 | ⤷ Subscribe | |
Philippines | 19771 | AZABICYCLOALKANE CARBOXYLIC ACIDS AND ESTERS | ⤷ Subscribe |
Germany | 3280014 | ⤷ Subscribe | |
Australia | 559140 | ⤷ Subscribe | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TARKA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0265685 | C980030 | Netherlands | ⤷ Subscribe | PRODUCT NAME: FELODIPINE, DESGEWENST IN DE VORM VAN FYSIOLOGISCH AANVAARDBAAR ZOUT, EN (2S, 3AS, 6AS)-1-[(S)-N-[(S)-1-CARBOXY-3-FENYLPROPYL]A LANYL]OCTAHYDROCYCLOPENTA[B]-PYRROOL-2-CARBONZUUR (RAMIPRILAAT) , DESGEWENST IN DE VORM VAN EEN .....ZIE VERDER IN HET DOSSIER; NAT. REGISTRATION NO/ DATE: RVG 22449, RVG 22450 19980618; FIRST REGISTRATION: SE 13596, 13597 19970919 |
0084164 | SPC/GB93/146 | United Kingdom | ⤷ Subscribe | SPC/GB93/146:, EXPIRES: 20070218 |
0265685 | 99C0001 | Belgium | ⤷ Subscribe | PRODUCT NAME: FELODIPINUM + RAMIPRILUM; NATL. REGISTRATION NO/DATE: 354 IS 373 F 3 19981103; FIRST REGISTRATION: SE 13597 19970919 |
0265685 | SPC/GB98/047 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: COMBINATIONS OF RAMIPRIL, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND FELODIPINE, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: SE 13596 19970919; SE 13597 19970919; UK 00017/0402 19980825; UK 00017/0403 19980825 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
TARKA Market Analysis and Financial Projection Experimental
More… ↓